ReviewActa pharmaceutica Sinica. B2024

A systematic, updated review of Xuezhikang, a domestically developed lipid-lowering drug, in the application of cardiovascular diseases.

Cheng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.